However, increased quartiles of maternal I-FABP and greater anti-LPS IgA concentrations, biomarkers of EED (gut epithelial damage and microbial translocation respectively), were associated with increased risk of stillbirth, a secondary outcome. The gene discussed is CD79A; the disease is Stillbirth.